Langsung ke konten

Onkologi

Pendekatan Multimodal, Interdisiplin, dan Individual

Complex liver resection for a large intrahepatic cholangiocarcinoma in a Jehovah's Witness: a strategy to avoid transfusion. (terbuka di window baru)

Barakat O, Cooper JR Jr, Riggs SA, Hoef JW, Ozaki CF, Wood RP.

Sumber‎: J Surg Oncol 2007;96(3):249-53.

Index‎: PubMed 17443725

DOI‎: 10.1002/jso.20799

https://www.ncbi.nlm.nih.gov/pubmed/17443725 (terbuka di window baru)

Long-lasting extreme anemia during the therapy of acute lymphoblastic leukemia in a Jehovah's Witness patient. (terbuka di window baru)

Chojnowski K, Janus A, Bliźniewska K, Robak M, Treliński J.

Sumber‎: Transfusion 2016;56(10):2438-42.

Index‎: PubMed 27385671

DOI‎: 10.1111/trf.13703

https://www.ncbi.nlm.nih.gov/pubmed/27385671 (terbuka di window baru)

Impact of a patient blood management program and an outpatient anemia management protocol on red cell transfusions in oncology inpatients and outpatients. (terbuka di window baru)

Gross I, Trentino KM, Andreescu A, Pierson R, Maietta RA, Farmer S.

Sumber‎: Oncologist 2016;21(3):327-32.

Index‎: PubMed 26865590

DOI‎: 10.1634/theoncologist.2015-0406

https://www.ncbi.nlm.nih.gov/pubmed/26865590 (terbuka di window baru)

Pancreas and liver resection in Jehovah's Witness patients: feasible and safe. (terbuka di window baru)

Konstantinidis IT, Allen PJ, D'Angelica MI, Dematteo RP, Fischer ME, Grant F, Fong Y, Kingham TP, Jarnagin WR.

Sumber‎: J Am Coll Surg 2013;217(6):1101-7.

Index‎: PubMed 23880361

DOI‎: 10.1016/j.jamcollsurg.2013.05.020

https://www.ncbi.nlm.nih.gov/pubmed/23880361 (terbuka di window baru)

The treatment of acute lymphoblastic leukemia in Jehovah's Witnesses and patients who cannot accept blood products. (terbuka di window baru)

Nguyen N, Madarang E, Alencar A, Watts J, Bradley T

Sumber‎: Leuk Res Rep. 2022 25;18:100355.

Index‎: PubMed 36338830

DOI‎: 10.1016/j.lrr.2022.100355

https://pubmed.ncbi.nlm.nih.gov/36338830/ (terbuka di window baru)